Stock Events

Stock Events

TC BioPharm (Holdings) 

0
55
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Allogene Therapeutics
ALLO
Mkt Cap680.62M
Allogene Therapeutics, Inc. works on allogeneic CAR T therapies for cancer, competing in the cell therapy space.
CRISPR Therapeutics
CRSP
Mkt Cap5.39B
CRISPR Therapeutics AG is involved in gene editing and cell therapy for cancer, directly competing in the innovative treatment space.
Gilead Sciences
GILD
Mkt Cap187.23B
Gilead Sciences, Inc. has a strong presence in cell therapy for cancer through its subsidiary Kite Pharma, making it a direct competitor.
Novartis
NVS
Mkt Cap304.1B
Novartis AG has approved CAR T-cell therapies in the market, making it a leading competitor in the cell therapy space.
Precigen
PGEN
Mkt Cap2.54B
Precigen, Inc. focuses on gene and cell therapies, including CAR T-cell therapies, competing in the same innovative treatment sector.

About

TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat COVID-19. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.
Show more...
CEO
Mr. Bryan Leland Kobel
Employees
41
Country
United Kingdom
ISIN
US87807D6085

Listings

OTC Link
US
TCBWF
STU
DE
T0U0.STU

0 Comments

Share your thoughts

FAQ

What is TC BioPharm (Holdings) stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange TC BioPharm (Holdings) stocks are traded under the ticker T0U.STU.
How many employees does TC BioPharm (Holdings) have?▼
As of September 09, 2026, the company has 41 employees.
In which sector is TC BioPharm (Holdings) located?▼
TC BioPharm (Holdings) operates in the Health & Wellness sector.
When did TC BioPharm (Holdings) complete a stock split?▼
The last stock split for TC BioPharm (Holdings) was on January 07, 2025 with a ratio of 1.25:1.
Where is TC BioPharm (Holdings) headquartered?▼
TC BioPharm (Holdings) is headquartered in Motherwell, United Kingdom.